| Tag | Content |
|---|
EnhancerAtlas ID | HS105-30391 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr16:28956610-28957310 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr16:28957040-28957059 | CAGCTCCACCTGCTGGCTG | - | 6.79 | | STAT1 | MA0137.3 | chr16:28957028-28957039 | TTTCCTGGAAA | - | 6.62 | | Stat4 | MA0518.1 | chr16:28957025-28957039 | CCGTTTCCTGGAAA | - | 7.95 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_54362 | chr16:28956447-28957452 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I028945 | chr16 | 28956522 | 28957610 |
|
Enhancer Sequence | ACTTGAGAGG CTGAGCAGGA GAATCGCTTG AACCCAGGAG GCGGATGTTG CAGTGAGCCG 60
AGATCACGCC ACTGCACTCC AGCCTGGCAA CAGAGCGAGA CTCCGTCTCA AACAAAAACA 120
AAAACAAAAA ACAGAGATGA GGTCTCGCTA TGTGTGCCCA GGCTAGCCTT GAGCTCCTGG 180
ACTCAAGCAA TCTTCCCATC TCAAGCATTC CTAGTAGCTG GGACTTACAG GTGCACTTTC 240
AGCTCTTGAG CAAGGTTTGG GGAAAGGAGA CTTGAAAATT TTAGACTCTC AGGGCCACCT 300
CCTGCTTGCG GTTTGCAGTG GTTTCCCGGG AGCGCCCAAG ACTGGCCTGC CGCCTGGCTA 360
CAGAGAGAGG CTGAAGGCCT CCTGGGGCTG GGAAGTCGGT GGAGTCCAGG AGCCTCCGTT 420
TCCTGGAAAA CAGCTCCACC TGCTGGCTGT TGTGCGCCTG CAGTCCTGAC CTTGGCGGAG 480
TCTGCACGGG GAAGGGAAAT GCATGCTGGT CCAGCGGGGG GCGCCTGCAG GGGACATCGG 540
TGCCGCGGTT GGGATGGAGG CGTATGGGAT GAGACTAGGG CAGAGGTGGA CATGCCGTTC 600
TGCGTGGATG TATGAGGCGC GAGTTTTGTG AGCACCGTGG GTGTGAGCAG CATGTGGTAT 660
TGGGTGTGTG CGGTGTGGGT ATCCTGAGCG ACGTGTGGCG 700
|
